

The study of ability to integrate with the recipient cornea of xenomaterial “Corneoplast” for keratoplasty in the animal experiment
https://doi.org/10.33791/2222-4408-2023-1-49-55
Abstract
Currently, there is a significant shortage of donor materials for replacing corneal tissue that is why it is relevant to create xenomaterials, which are able to replace a donor cornea with various types of keratoplasty. “Corneoplast” is a new medical device, which is a devitalized, fixed by the method of double crosslinking (dehydrothermic + UV), pork cornea.
Purpose: to assess the biocompatibility and ability to integrate with the recipient cornea of implants based on the xenomaterial “Corneoplast”.
Materials and methods. The experiment was based on biomicroscopy examination, high-resolution optical coherence tomography and histological examination of the experimental rabbits’ corneas (group I–IV: total of 8 eyes were examined), where keratoplasty was performed with the “Corneoplast” material.
Results. High biocompatibility and ability to integrate with the recipient’s cornea were observed in all types of keratoplasty: penetrating, superficial lamellar and intralamellar keratoplasty. On the next day, the implant was transparent with slight swelling of the recipient’s corneal stroma. A week later, the slight swelling of implant was recorded without cornea edema. Its transparency decreased. The recipient’s cornea was reactive. A month later, the moderate neovascularization was noted towards the sutures. After 6 months, the recipient’s cornea was clear, transparent. The implant was translucent and neovascularization was absent. The entire surface of cornea and implant was epithelialized. On the series of optical coherent tomograms, a normal thickness of the epithelium continuous layer was determined in 6 months after the surgery. The complete integration of material with the recipient’s cornea was noted. The layered structure characteristic of corneal tissue was preserved. The cornea retained a layered structure and the endothelium was preserved. On histological examination, there were no differences in the intact cornea and implanted material.
Conclusion. The “Corneoplast” material is sufficiently biocompatible and capable of integration with the recipient’s cornea in an animal experiment. This allows, at a certain stage of preclinical trials completion, to use it for replacing corneal tissue in penetrating keratoplasty, intralamellar and superficial anterior layer-by-layer implantations and to cover purulent corneal ulcers of various depths.
About the Authors
S. I. AnisimovRussian Federation
Sergey I. Anisimov, Dr. Sci. (Med.), Scientific Director; Professor of the Department of Eye Diseases
10/1, Polini Osipenko Str., Moscow, 123007, Russian Federation
20/1, Delegatskaya Str., Moscow, 127473, Russian Federation
N. S. Anisimova
Russian Federation
Natalia S. Anisimova, Cand. Sci. (Med.), Chief Physician; assistant at the Department of Eye Diseases
10/1, Polini Osipenko Str., Moscow, 123007, Russian Federation
20/1, Delegatskaya Str., Moscow, 127473, Russian Federation
I. A. Popov
Russian Federation
Ilya A. Popov, Cand. Sci. (Med.), Ophthalmologist
10/1, Polini Osipenko Str., Moscow, 123007, Russian Federation
A. G. Shilkin
Russian Federation
Alexey G. Shilkin, Chief Veterinary Physician
43, Ostrovityanova Str., Moscow, 117342, Russian Federation
M. N. Orlova
Russian Federation
Maria N. Orlova, Postgraduate Student
43, Ostrovityanova Str., Moscow, 117342, Russian Federation
23, Akademika Skryabina Str., Moscow, 109472, Russian Federation
References
1. Shi W., Zhou Q., Gao H. et al. Protectively decellularized porcine cornea versus human donor cornea for lamellar transplantation. Advanced Functional Materials 2019;29(37):1902491. https://doi.org/10.1002/adfm.20190249
2. Chodosh J., Ilios E.P., Graney J. Keratoprothesis apparatuses, systems, and methods: U.S. Patent №. 10939993. Washington, DC: U.S. Patent dated 2021.
3. Borzenok S.А., Moroz Z.I., Kalinnikov Yu.Yu. et al. Means for preserving the donor cornea with a supporting element of the keratoprosthesis. Patent № 2204247 dated 27.11.2003. (In Russ.) 4. Pang K., Du L., Wu X. A rabbit anterior cornea replacement derived from acellular porcine cornea matrix, epithelial cells and keratocytes. Biomaterials. 2010, Oct;31(28):7257–7265. https://doi.org/ 10.1016/j.biomaterials.2010.05.066
4. Luo H., Lu Y., Wu T. et al. Construction of tissue-engineered cornea composed of amniotic epithelial cells and acellular porcine cornea for treating corneal alkali burn. Biomaterials. 2013;34(28):6748–6759. https://doi.org/10.1016/j.biomaterials.2013.05.045
5. Wu Z., Zhou Y., Li N. et al. The use of phospholipase A(2) to prepare acellular porcine corneal stroma as a tissue engineering scaffold. Biomaterials. 2009;30(21):3513–3522. https://doi.org/10.1016/j.biomaterials.2009.03.003
6. Hashimoto Y., Funamoto S., Sasaki S. et al. Preparation and characterization of decellularized cornea using high-hydrostatic pressurization for corneal tissue engineering. Biomaterials. 2010;31(14):3941–3948. https://doi.org/10.1016/j.biomaterials.2010.01.122
7. Moroz Z.I., Borzenok S.A., Kalinnikov Yu.Yu. Method of processing human cadaveric keratoderma preceding keratoplasty. Patent № 2381649 dated 20.02.2010. (In Russ.)
8. Gorohova M.V. Keratoplasty using cross-linking modified donor material in patients with corneal ulcers. Thesis for the degree of candidate of medical science. Moscow; 2017. 132 p. (In Russ.)
Review
For citations:
Anisimov S.I., Anisimova N.S., Popov I.A., Shilkin A.G., Orlova M.N. The study of ability to integrate with the recipient cornea of xenomaterial “Corneoplast” for keratoplasty in the animal experiment. The EYE GLAZ. 2023;25(1):49-55. (In Russ.) https://doi.org/10.33791/2222-4408-2023-1-49-55